rs145088115

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_006842.3(SF3B2):​c.401G>A​(p.Arg134His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,612,356 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R134P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00040 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

SF3B2
NM_006842.3 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.27

Publications

0 publications found
Variant links:
Genes affected
SF3B2 (HGNC:10769): (splicing factor 3b subunit 2) This gene encodes subunit 2 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence-independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. Subunit 2 associates with pre-mRNA upstream of the branch site at the anchoring site. Subunit 2 also interacts directly with subunit 4 of the splicing factor 3b complex. Subunit 2 is a highly hydrophilic protein with a proline-rich N-terminus and a glutamate-rich stretch in the C-terminus. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0106675625).
BP6
Variant 11-66055218-G-A is Benign according to our data. Variant chr11-66055218-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3794761.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 61 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SF3B2NM_006842.3 linkc.401G>A p.Arg134His missense_variant Exon 4 of 22 ENST00000322535.11 NP_006833.2 Q13435
SF3B2XM_005273726.5 linkc.401G>A p.Arg134His missense_variant Exon 4 of 22 XP_005273783.1
SF3B2XM_011544740.4 linkc.401G>A p.Arg134His missense_variant Exon 4 of 22 XP_011543042.1
SF3B2XM_017017144.3 linkc.401G>A p.Arg134His missense_variant Exon 4 of 22 XP_016872633.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SF3B2ENST00000322535.11 linkc.401G>A p.Arg134His missense_variant Exon 4 of 22 1 NM_006842.3 ENSP00000318861.6 Q13435

Frequencies

GnomAD3 genomes
AF:
0.000402
AC:
61
AN:
151852
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000232
AC:
58
AN:
249764
AF XY:
0.000200
show subpopulations
Gnomad AFR exome
AF:
0.00205
Gnomad AMR exome
AF:
0.000550
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000445
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000726
AC:
106
AN:
1460386
Hom.:
0
Cov.:
33
AF XY:
0.0000730
AC XY:
53
AN XY:
726440
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33440
American (AMR)
AF:
0.000425
AC:
19
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53208
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5748
European-Non Finnish (NFE)
AF:
0.0000252
AC:
28
AN:
1111056
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000401
AC:
61
AN:
151970
Hom.:
1
Cov.:
32
AF XY:
0.000431
AC XY:
32
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41512
American (AMR)
AF:
0.000654
AC:
10
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10506
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67966
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000161
Hom.:
0
Bravo
AF:
0.000502
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000255
AC:
31
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Feb 20, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0084
T;T;T;.;.;T
Eigen
Benign
0.092
Eigen_PC
Benign
0.21
FATHMM_MKL
Benign
0.50
D
LIST_S2
Uncertain
0.86
D;D;D;D;D;D
M_CAP
Benign
0.0033
T
MetaRNN
Benign
0.011
T;T;T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.58
.;N;.;.;.;.
PhyloP100
1.3
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
0.080
N;N;N;N;N;D
REVEL
Benign
0.069
Sift
Benign
0.065
T;D;T;T;T;.
Sift4G
Benign
0.16
T;T;T;T;T;T
Polyphen
0.97, 1.0
.;D;.;D;.;.
Vest4
0.15
MVP
0.26
MPC
1.4
ClinPred
0.028
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.027
gMVP
0.079
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145088115; hg19: chr11-65822689; API